Skip to contentClarengateINTELLIGENCE
Coverage & freshness About Clarengate
Companies/SC658917

Nodus Oncology Limited

Research and experimental development on biotechnology · Edinburgh

ActiveUnited KingdomIncorporated 2020Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2022-04-30

IXBRL · 32 source facts · 12 selected values

Not assessed
legacy record
Reporting period
2021-05-01 to 2022-04-30
Extraction status
Legacy / not assessed
Numeric facts
12
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0108_SC658917_20220430
Source archive
Accounts_Monthly_Data-July2022.zip

Accounts to 2021-04-30

IXBRL · 26 source facts · 6 selected values

Not assessed
legacy record
Reporting period
2020-04-06 to 2021-04-30
Extraction status
Legacy / not assessed
Numeric facts
6
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0095_SC658917_20210430
Source archive
Accounts_Monthly_Data-October2021.zip

Registered details

SC658917
Status
Active
Type
Private Limited Company
Incorporated
2020-04-06
Jurisdiction
—
Registered office
361, DUBLIN STREET, EDINBURGH, MIDLOTHIAN, EH3 6NL, SCOTLAND

Classification

2 SIC codes
7211072190

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

2 SH01-derived rounds
2023-12-21
£1,799,981 raised
£8,951,538 estimated post-money
2023-02-01
£2,399,863 raised
£6,472,455 estimated post-money

Research and innovation

0 matched grants

No matched UKRI or Innovate UK awards.